RNA-seq
Cells were infected with a lentivirus vector expressing shRNA #3 against EZH2 ( Figure 1E -H) and cells were harvested at 4 and 8 days after infection. Total RNA was harvested from cells using Trizol reagent (Invitrogen) and further purified using the Purelink RNA Mini kit (Invitrogen) with DNase I digestion. RNA library preparation with polyA selection and Illumina HiSeq 2x150bp sequencing was performed by GeneWiz Inc. Paired-end reads were quality trimmed using Trim galore v0.4.0 and subsequently aligned to the human reference genome, hg19, using HISAT2 v2.1.0. Reads mapping to annotated genes were quantified using featureCounts (Liao et al., 2014) . Differential gene expression was determined using DESeq2 v1.12.4 (Love et al., 2014) and significance was defined as FDR-corrected p-values of <0.05. The log2 fold change for each gene was used to rank the list of genes for GSEAPreranked analysis (Subramanian et al., 2005) . FPKM values were calculated using DESeq2 and Z-scores were generated from FPKMs. Upstream regulators were identified using Ingenuity Pathway Analysis (IPA, Qiagen) with default settings. The cutoffs used were p <0.05 and absolute fold-change >1.75. The differential expression and alignment rates are shown in Table S4 , and the DESeq2 output for the entire dataset in Table S5 .
Immunofluorescence and ImmunoFISH
Nonspecific binding solution contained 4% bovine serum albumin (BSA; Thermo Fisher Scientific), 2% donkey serum, and 0.1% Triton X-100 in PBS. The antibodies used were as follows: Santa Cruz, p16 (sc-756, 1:100), p21 (sc-397; 1:100); Millipore, gH2AX (05-636, 1:100); Becton Dickinson, 53BP1 (NB100-304, 1:100); Cell Signaling, phospho-ATM (Ser1981, 4526, 1:100), EZH2 (5246, 1:100). The rabbit polyclonal antibody against human mH2A was a kind gift from Dr. Peter Adams (University of Glasgow) and was used as indicated before (Kreiling et al., 2011) . For the TIF assay (Herbig et al., 2004) , cells were first fixed, permeabilized and immuno-stained for 53BP1 as described above. The samples were then dehydrated in a 70%, 90%, and 100% ethanol (3 min. each) and air dried. Nuclear DNA was denatured for 5 min. at 80°C in hybridization buffer containing 0.5 µg/ml Cy5-conjugated peptide nucleic acid (PNA) telomere C probe (PNA bio, #F1003), 70% formamide, 12 mM Tris HCl (pH 8), 5 mM KCl, 1 mM MgCl2, 0.001% Triton X-100, and 2.5 mg/ml acetylated BSA. After denaturation, incubation was continued for 14 hrs. at room temperature in a humidified chamber. Cells were washed two times for 15 min. with 70% formamide in 2x SSC (0.3 M NaCl, 30 mM Na-citrate), followed by a 10 min. wash with 2x SSC, and a 10 min. wash with PBS. For EdU incorporation, cells were treated for 24 hours with EdU and processed as instructed by the manufacturer (Life Technologies, #C10337).
Cytokine Array
Cultures were washed three times with PBS and incubated in serum-free medium for 24 hrs. The conditioned media (CM) were collected and centrifuged at 1000 x g for 10 min. at 4°C. The CM were diluted in proportion to the cell number and analyzed using the Quantibody Human Cytokine Array 1 (QAH-CYT-1, RayBiotech) as per manufacturer's instructions. The signals were detected with a GenePix 4200B microarray scanner.
Detection of SA-β-Gal Activity
Cells grown on coverslips were fixed with 0.2% glutaraldehyde and 2% formaldehyde for 5 min., washed twice with PBS, and incubated overnight at 37°C in a staining solution (DebacqChainiaux et al., 2009 ) containing 5-bromo-4-chloro-3-indolyl-β-galactopyranoside. Site-directed mutagenesis EZH2 mutant (S652A and S734A), EZH2 deletion (EZH2ΔSET) and EED mutant (F97A, W364A, and Y365A) were generated by using the QuikChange Lightning Site-Directed Mutagenesis kit (Agilent Technologies). All constructs were confirmed by sequencing. Expression and Knockdown of EZH2 and Phenotypes of Senescent Cells (A) Cells were serially propagated under standard culture conditions. Onset of senescence was designated as the zero time point, at which >95% of the cells in the culture were SA-β-Gal positive. The points in the graph correspond to the lanes shown in Figure 1D. (B) Levels of EZH2 protein and the H3K27me3 mark were examined by immunoblotting in HDF strains WI-38 and IMR90 at early passage (E) and 5 weeks after the onset of senescence (S). (C) LF1 early passage, replicatively senescent, and serum-starved quiescent cells were assayed for SA-β-Gal activity and EdU incorportation (**p<0.01, n=3). (D) EZH2 protein levels were examined by immunoblotting in samples from panel (C). (E) Cells were treated with etoposide (Eto, 40 µM) at the zero time point and levels of EZH2 protein and H3K27me3 marks were examined by immunoblotting. EZH2 and H3K27me3 levels were normalized to GAPDH (green and red plots, respectively). (F) SA-β-Gal positive cells were scored in the etoposide treatment experiment shown in panel (E) (*p<0.05, **p<0.01, n=3). (G) Schematic overview and timeline of lentivirus shRNA infection experiments. Cells were infected with lentiviral particles for a total of 2 days. After a wash and 12 hrs further incubation the cultures were replated, and this time point was designated as t=0 for all the time courses presented in this study. Cells were treated with puromycin for 2 days, at which time all sensitive cells had been effectively removed. Cells were harvested at successive time points as indicated in individual experiments. (H) LF1 cells were infected with lentivirus vectors expressing three different shRNAs against the EZH2 transcript. The effectiveness of knockdowns was examined by RT-qPCR for the EZH2 mRNA 2 days after infection (**p<0.01, n=3). shRNA against GFP was used as the control. The shRNAs used are listed in the Extended Experimental Procedures. (I) EZH2 was knocked down as described in Figure 1E . Representative images of cells displaying SAHF and SA-β-Gal activity are shown. SAHF formation was visualized by DAPI staining. Images were acquired 2 days after infection with EZH2 shRNA. (J) EZH2 was knocked down as in panel I and mH2A expression was examined using IF microscopy. (K) mH2A nuclear signals were quantified in the IF images using ImageJ software and plotted as histograms of cell number (% of total) against fluorescent intensity in arbitrary units (a.u.). At least 260 nuclei were observed for each condition. Error bars represent SD. 
Microscopy

RNA-seq Analysis of Global Gene Expression Changes Elicited by Knockdown of EZH2
(A-B) EZH2 was knocked down as described in Figure 1E and RNA-seq was performed on RNA harvested on day 4 and 8 after infection. The data were analyzed using GSEA and the top 5 upregulated and downregulated GO process pathways, ranked by normalized enrichment score (NES), are shown for 4 days (A) and 8 days (B) after infection. (C) Upstream Regulator analysis was performed using IPA and the 8 most activated or inhibited regulators are shown at 8 days after EZH2 knockdown. See also Tables S4, S5 . Figure 1E and expression of p21 mRNA was measured by RT-qPCR at 4 and 8 days after infection (**p<0.01, n=3). (B) Expression of p16 was determined in the experiment shown in (A). (C) Cells grown continuously in the presence of DZNep (5 µM) for 9 days were assayed for EdU incorporation (**p<0.01, n=3). (D) Expression of the indicated genes was determined by RT-qPCR in cells treated with DZNep for 9 and 18 days. The data are represented as heat maps relative to vehicle (DMSO) control (n=3). (E) A double knockdown of EZH2 and p21 was performed as described in Figure 2F , and the levels of p21 protein were determined by immunoblotting. The control for EZH2 knockdown was shGFP, and for p21, the empty vector. (F-G) A double knockdown of EZH2 and p21 was performed as above and proliferation was assessed by cell number (F) or EdU staining (G) (*p<0.05, **p<0.01, n=3). (H-I) A double knockdown of EZH2 and ATM was performed and proliferation was assessed by cell numbers (H) or EdU staining (I) (*p<0.05, **p<0.01, n=3). Figure 2I , and p21, p16 and EZH2 protein levels were determined by immunoblotting (M) or assayed for SA-β-Gal activity (N) 4 days after infection (**p<0.01, n=3). Error bars represent SD. Inhibition of EZH2 Activity Induces Senescence by Depleting H3K27me3 Marks and Activating p16 and SASP Genes (A) Cells were continuously treated with the drug GSK126 (5 µM) or vehicle (DMSO) for 20 days and then assayed for EdU incorporation (** p<0.01, n=3). (B) Cells were infected with lentivirus vectors expressing EZH2 or EZH2ΔSET cDNAs, or empty vector as control (as in Figure 3G ), and p16, p21 and H3K27me3 levels were determined by immunoblotting 9 days after infection. (C-D) In the experiment shown in (B) above, expression of p16 and p21 mRNAs was determined by RT-qPCR (C) and proliferation was assessed by EdU incorporation (D) (** p<0.01, n=3). (E) In the experiment shown in (B) above, 53BP1 foci were visualized by IF (n=3). (F) Cells were made quiescent by incubation in medium supplemented with 0.25% FBS and then treated with GSK126 (5 µM) for the indicated times. Levels of the H3K27me3 mark were determined by immunoblotting. (G) Cells were treated with GSK as in (F) above for 21 days and immunostained with antibodies to p16. Nuclei were counterstained with DAPI. The frequency of p16-expressing cells is shown in the right panel (% of total cells, random fields, >200 cells per condition, **p<0.01). (H) Cells were treated with GSK126 (5 µM) or DMSO for 10 days and H3K27me3 and H3K27ac enrichment at the enhancer between the MMP3 and MMP12 loci was determined by ChIP-qPCR. Normal rabbit IgG was used as the IP control (** p<0.01, n=3). Location of the primer pair is indicated in the schematic on right. The IMR90 H3K27ac and H3K4me1 tracks were obtained from ENCODE (GEO ID: GSM469966 and GSM521895). (I) Cells were treated with GSK126 (5 µM), JQ1 (100 nM) or both, and levels of the p16 protein were determined by immunoblotting after 10 days. (J) Cells were treated as in (I) and the frequency of SA-β-Gal positive cells was determined (* p<0.05, ** p<0.01, n=3). (K) Cells were treated with GSK126 for 10 days, followed by 4 days of combined treatment with GSK126 and rapamycin (12.5 nM). Expression of the indicated SASP genes was determined by . The data are expressed as heat maps relative to control (vehicle-treated) cells. (L) Cells were treated as in (K) and IkBα protein levels were determined by immunoblotting. Error bars represent SD. Fig 
